Andrew Bridge, MD
Dermatology · Carmel, INNPI 1174780837
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.5%), consulting fees and education — rather than concentrated in one kind of arrangement. 28 manufacturers reported payments, led by Tanabe Pharma America, Inc. at 36.5% of the total. Reporting peaked in 2023 at $1,098 and has fallen 53.2% since, to $514 in 2025. That places this record below the midpoint for dermatology clinicians in IN, where the typical reported total is $3,818.
Across 91 payments — averaging $36.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tanabe Pharma America, Inc.$1K
- Johnson & Johnson$690
- AbbVie$280
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$147
- Lilly USA, LLC$124
- Sun Pharmaceutical Industries Inc.$113
- plus $775 from 22 others
Across 1 payment — averaging $11,400 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Mitsubishi Tanabe Pharma Development America, Inc.$11K
What the payments were for
- Consulting fees$1,32540%
- Food & beverage$1,79554%
- Education$2347%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tanabe Pharma America, Inc. | 7 | $1,225 |
| Johnson & Johnson | 12 | $690 |
| AbbVie | 13 | $280 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $147 |
| Lilly USA, LLC | 7 | $124 |
| Sun Pharmaceutical Industries Inc. | 7 | $113 |
| Mitsubishi Tanabe Pharma Development America, Inc. | 1 | $100 |
| Pfizer | 6 | $87 |
| Incyte Corporation | 2 | $80 |
| Mayne Pharma Commercial LLC | 4 | $59 |
| Novartis | 4 | $50 |
| Abbott | 2 | $43 |
| Amgen | 2 | $40 |
| Dermira, Inc. | 2 | $40 |
| Chiesi USA, Inc. | 1 | $39 |
| GSK | 2 | $35 |
| Merck | 2 | $27 |
| Corcept Therapeutics | 1 | $24 |
| EPI Health, LLC | 1 | $24 |
| Janssen Scientific Affairs, LLC | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $21 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $19 |
| Exact Sciences | 1 | $17 |
| Genentech USA, Inc. | 1 | $15 |
| Almirall LLC | 1 | $14 |
| VYNE Pharmaceuticals Inc. | 1 | $13 |
| Journey Medical Corporation | 1 | $4 |
| Prugen, Inc. Pharmaceuticals | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,354 in reported general payments places this provider in the 45th percentile of 202 dermatology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 56 | $216,491 |
| Humira(Cf) PenAdalimumab | 12 | $85,564 |
| Acitretin | 17 | $5,441 |
| Fluorouracil | 42 | $3,625 |
| Clobetasol Propionate | 80 | $2,585 |
| Minocycline Hcl | 88 | $2,233 |
| Triamcinolone Acetonide | 160 | $1,918 |
| Dapsone | 39 | $1,830 |
| Doxycycline Hyclate | 50 | $1,775 |
| Hydroxyzine Hcl | 88 | $1,705 |
| Tretinoin | 20 | $1,497 |
| Mycophenolate Mofetil | 12 | $1,480 |
| Azelaic Acid | 13 | $1,293 |
| Cyclosporine ModifiedCyclosporine, Modified | 15 | $1,085 |
| Doxycycline Monohydrate | 43 | $1,053 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Carmel
- John StephensCarmel$17K
- Robert DazeCarmel$10K
- Lisa TrivediCarmel$8K
- Scott GuenthnerPlainfield$1.6M
- David RosmarinIndianapolis$1.1M
- Christopher ObeimeIndianapolis$907K
- Scott FretzinIndianapolis$794K
- Priya YoungIndianapolis$492K
- Jeffrey SassmannshausenFort Wayne$489K
- Nikolajs PerdueIndianapolis$302K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.